The goal of the 340B pricing program is to:

• A. Provide affordable medications to low-income or rural populations
• B. Increase profits for manufacturers
• C. Expand product selection in urban areas
• D. Reduce regulatory oversight

Answer: (A)

At its heart, the 340B pricing program is about expanding access to affordable medicines for people with limited means. Drug manufacturers provide discounts to eligible safety-net providers—like certain hospitals and clinics—so these organizations can buy medications at reduced prices and use the savings to treat more patients, including those who are low-income or in rural areas. This helps stretch finite resources to improve care and access to medications for underserved populations. The other options miss the point: the program isn’t designed to boost manufacturers’ profits, expand product listings, or reduce regulatory oversight.